Announcements

8 July 2026
MDPI’s Newly Launched Journals in June 2026


Our portfolio of journals available for publishing up-to-date research in immediate open access format has been further expanded. In June 2026, eleven new journals released their inaugural issues and two transferred journals released their first issue as part of MDPI, covering the subjects of environmental & earth sciences, chemistry & materials science, public health & healthcare, engineering, medicine & pharmacology, and biology & life sciences. 

We extend our gratitude to the Editors-in-Chief, Associate Editors, and Editorial Board Members who will shape the future course of these new journals. Each journal is dedicated to upholding strong editorial standards through a thorough peer review process, enabling impactful open access scholarship. 

Please feel free to browse and discover more about the new journals below. 

New Journals

Founding Editor(s)-in-Chief

Journal Topics (Selected)

Prof. Dr. Xiaochuan Pan,

Peking University, China

Editorial | view inaugural issue

public health research, practice, policy, and education; eco-health equity |

view journal scope | submit an article

Prof. Dr. Xin-Gao Gong

Fudan University, China;

Prof. Dr. Zhimei Sun

Beihang University, China

Editorial | view inaugural issue

AI-enhanced theory & simulation; generative design & discovery; autonomous experimentation; AI for characterization; large language models and agents |

view journal scope | submit an article

Prof. Dr. Yong Liu,

Wuhan University, China

Editorial | view inaugural issue

hydropower technology; renewable energy; water resources; optimization; rock and soil mechanics; power system stability |

view journal scope | submit an article

Prof. Dr. Giovanni Rezza,

University Vita-Salute San Raffaele, Italy

Editorial | view inaugural issue

pandemic preparedness; public health; global outbreak dynamics and epidemiology; outbreak prediction and risk forecasting; one health approach; zoonotic and pre-pandemic vaccines |

view journal scope | submit an article

Prof. Dr. Brian Horton,

University of Texas at Austin, USA

Editorial | view inaugural issue

stratigraphy; sedimentology; earth surface processes; basin evolution and tectonics; climate and paleoclimate |

view journal scope | submit an article

Prof. Dr. Yike Guo,

Hong Kong University of Science and Technology, China

Editorial | view inaugural issue

artificial intelligence (AI); application of AI to engineering; Explainable AI (XAI); AI-driven design and optimization; AI for manufacturing and automation | view journal scope | submit an article

Prof. Dr. Hei Wong,

City University of Hong Kong, China

Editorial | view inaugural issue

novel semiconductor materials; advanced heterogeneous integration technologies; advanced characterization and testing techniques; heterogeneously integrated systems and applications; modeling and design automation|

 view journal scope | submit an article

Prof. Dr. Michail Panagiotidis,

Mississippi State University, USA

Editorial | view inaugural issue

plant-based medicines; natural products-based drug discovery; plant-based bioactive compounds; pharmacognosy; phytochemicals; pharmacokinetics |

view journal scope | submit an article

Prof. Dr. Khalid Meksem,

Southern Illinois University, USA

Editorial | view inaugural issue

genome biotechnology; applied genomics; genetic engineering; agricultural biotechnology; medical biotechnology; data science and AI|

view journal scope | submit an article

Dr. Chenxi Wu,

Chinese Academy of Sciences, China

Editorial | view inaugural issue

environmental cleanup; ecological restoration; environmental management and governance; environmental modeling and monitoring |

view journal scope | submit an article

Prof. Dr. Janusz Kozinski,

Lakehead University, Canada

Editorial | view inaugural issue

renewable energy; sustainable agriculture; green innovation; climate change; artificial intelligence and environmental sustainability |

view journal scope | submit an article

Transferred Journals

Editor(s)-in-Chief

Journal Topics (Selected)

Prof. Dr. Thomas Frese,

Martin-Universität Halle-Wittenberg, Germany

Editorial | view first issue

health services in primary care; integrated care models; quality and safety of care; coordination across primary and secondary care services; patient management; primary care clinical practice and interventions; clinical interventions delivered in primary care settings;

view journal scope | submit an article

Prof. Dr. Paul Gerson Unschuld,

Geneva University Hospitals (HUG), Switzerland

Editorial | view first issue

neurology, psychiatry, psychotherapy, and the neurosciences |

view journal scope | submit an article

We would like to thank everyone who has supported the development of open access publishing. If you would like to create a new journal, you are welcome to send an application here or contact the New Journal Committee (newjournal-committee@mdpi.com).

8 July 2026
Honoring the Top 1000 Reviewers for 2025


Peer review is the invisible foundation of academic progress. The 2025 MDPI Top Reviewers are some of the key experts who helped build it.

We are honored to recognize 1000 individuals from our global community of 210,000 reviewers across 67 countries and territories—chosen for their commitment to rigorous, constructive peer review and the consistency of their contributions throughout 2025.

The Top Reviewers provided constructive and impartial feedback that makes research stronger and more impactful, and we are grateful for it.

The names of these reviewers are listed below in alphabetical order by first name:

A. N. M. Mamun-Or-Rashid

Han Wu

Nijia Qian

Abdallah Galal

Hani Nasser Abdelhamid

Nikola Petrović

Abdeljabbar Ghanmi

Hanstter Rezende

Nina Mendez-Dominguez

Abdelmalek Bellal

Han-Tsung Wang

Nora Ahmed

Abdelnasser Abidli

Hao Tang

Nurcan Kilinc-Ata

Abderrahim Ayad

Haodong Chen

Oğuzhan Çetindemir

Abdulkadir Atalan

Haoxuan Dong

Oksana Kovtun

Abid Ullah

Hassan Barakat

Oluwagbemiga Paul Agboola

Adeney De Freitas Bueno

Hassan Harb

Omar Alsetoohy

Agnieszka Synowiec

Hebat-Allah Sarhan Tohamy

Ömer Kaya

Agnishwar Girigoswami

Héctor Mora-Montes

Omneya Attallah

Agustín Ariño

Hengkai Li

Orestis M. Ioannidis

Ahmadjan Muhammadhaji

Hengrui Liu

Oscar Arias-Carrion

Ahmadreza Mohebbi

Hiroshi Matsuyama

Osmar Antonio Jaramillo Morales

Ahmed Gad

Ho Namgung

Palash Mandal

Ahmed Ghezal

HoangNam Tran

Panayiotis Iliakis

Ahmed Mohamed Nabil Helaly

Hongfen Zhu

Pargam Vashishtha

Ahmed Saad Rashed

Hongzhi Shen

Parisa Kaviani

Ahmet İhsan Turan

Hossein Lotfi

Patrycja Kleczkowska

Aidin Bordbar-Khiabani

Huajin Li

Paula Pinto

Alain Manuel Chaple Gil

Huayue Chen

Paulius Skačkauskas

Alan Gasiński

Hui Lu

Paulo Cezar Bastianello Campagnol

Albena Doicheva

Huseyin Cetin

Pavel Kic

Alberto Gallegos

Hyeong-Geun Kim

Pavlo Maruschak

Alejandro Cano-Villagrasa

Hyoungchul Shin

Paweł Ciężkowski

Aleksandr Bobrovskikh

Ibrahim Mohamed

Paweł Rydzewski

Aleksandra Figurek

Ibrahim Mosly

Pedro Valdivia-Moral

Aleksandra Jovanović

Ibtissam Bakkouri

Peng Chen

Aleksandra Rybak

Igor Schepetkin

Pengle Cheng

Alessandro Poggi

Ilias Lazos

Philippe Colomban

Alessio Castagnoli

Imen Barraj

Pier Nicola Sergi

Alexandre Pimenta

Imran Ali

Ping Zhu

Alexey Andreychev

Imtiaz Ahmad

Piotr Legutko

Alexey Beskopylny

Ioannis A. Giantsis

Piotr Lichota

Alexis Murillo Carrasco

Ioannis Vardiambasis

Poya Sohrabi

Alfredo Teixeira

Irina Georgescu

Pradeep Kumar Yadav

Ali Abd El-Aty

Isaac Adejumo

Prashant Singh

Ali Alshebami

Isabel Legaz

Prithviraj Nandigrami

Ali Ercetin

Isabel Maldonado

Przemysław Podulka

Ali Kandil

Isabel Marques

Qiang Peng

Alireza Shoari

Itamar Luís Gonçalves

Qiang Yao

Alok Tiwari

Ivan Laktionov

Qiaochu Li

Aman Muhammad

Ivan Šoša

Qichang An

Amgad Fahmy

Ivan V. Semenyuta

Qingqing Sun

Amira Mohamed Idrees

Izabela Zakrocka

Rabii El Maani

Amr Mohamed

Jae Hwan Lee

Radosław Balwierz

Amroune Salah

Jakub Ciazela

Rafat Ghanamah

Anastasia Ivanova

Jale Minibas-Poussard

Rajaram Rajamohan

Anastasios Koulaouzidis

Jamal Ayour

Rajendra Rohokale

Anatoli Popov

James A. Bunce

Raluca Isac

András Molnár

Janvier Habumugisha

Raluca Mureşan

André Luiz Missio

Jarogniew Łuszczki

Ramalingam Manikandan

André Pinto

Jasna Čanadanović Brunet

Rashad EL-Sagheer

André Rolim Baby

Jean-Louis Pinault

Rashid Dallaev

Andres Camargo-Sanchez

Jelena Petrović

Ravish Patel

Andrew Perry

Jesús Bernardo Páez-Lerma

Rehan Jamil

Andrey Kuskov

Jesus Jaquez-Muñoz

Renzo Pepe-Victoriano

Andrey Zamyatnin

Jia Wang

Ricardo Hernández-Martínez

Andrii Velychkovych

Jia Wen Li

Ricardo Luiz Fernandes Bella

Angeliki Papalou

Jia-Bin Wu

Ricardo Raimundo

Anita Sejben

Jianfeng Chen

Rina Zviel-Girshin

Anja Terzić

Jiangmin Ding

Ritthideach Yorsaeng

Anna Kamenskikh

Jiangxiong Zhu

Robinson J. Herrera-Feijoo

Anna Maria Kot

Jiangyu Zhu

Rocco Ditommaso

Antanas Laurincikas

Jianhua Ren

Rocco Vitis

Anton Tkachenko

Jianjian Zheng

Rodrigo Valenzuela

António Miguel Monteiro

Jianzhao Qi

Roman Dmytryshyn

António Portelada

Jiazhen Zhang

Roman Parovik

Antonios Christou

Jifu Li

Ronit Sionov

Antreas Kantaros

Jingcai Zhang

Ruben Rodríguez Elizalde

Arash Kardani

Joanna Kosałka-Węgiel

Ružica R. Nikolić

Arash Shams Taleghani

João Carlos Caetano Simões

Sadegh Ghaderi

Armand Faganel

Jonathan Soldera

Salih Özer

Artem Perepelitsyn

Jongbeom Lim

Saliha Karadayi-Usta

Ashraf Ali

Joon Hyuk Choi

Salvatore Falanga Bolognesi

Asif Ali Haider

Jorge L. Mejía-Méndez

Salvatore Simone

Atila Kumbasaroglu

José Ascención Martínez Álvarez

Sandeep Kumar Chamoli

Aurel Burciu

José Antonio Suarez-Navarro

Sandra Pascual-García

Aynur Aliyeva

José Carlos Vázquez-Parra

Sanjin Kovacevic

Ayushman Ramola

Jose Lavres Junior

Santiago Juan-Navarro

Azizollah Khormali

José Leija-Martínez

Santosh Reddy Addula

Baishu Guo

José Luis Aguirre-Noyola

Saravanan Ramasamy

Baoqiang Liu

José Ramiro Fernandes

Sasa Radoslav Bubanj

Bartłomiej Zieniuk

José Rodrigues

Saurabh Agarwal

Bartosz Kruszewski

Josef Yayan

Sayed Saber

Beata Dedicova

Juan Gabriel Avina-Cervantes

Sebastian Schnaubelt

Behnam Mobaraki

Juan Sebastián Fernández-Prados

Sergei G. Gaidin

Ben Ingram

Juan Vielma-Perez

Sergii Sagin

Bernardo Tutikian

Jui-Hsiang Lee

Serife Balikci

Bhupinder Kumar

Junhe Yu

Seweryn Lipiński

Biao Luo

Jun-Sheng Zhang

Shadfar Davoodi

Bin Wang

Justin Nnaemeka Onyeukaziri

Shamsaldeen Ibrahim Saeed

Bin Yan

K. S. Anandh

Shanmugam Vignesh

Binfeng Yin

Kaibing Zhou

Shaohua Lei

Bing He

Kakarla Ramakrishna

Sheng Chang

Bingnan Guo

Kamil Henryk Nelke

Shengqun Deng

Bingzhe Zhang

Kamran Shah

Shigeru Kanemitsu

Bishal Baniya

Karina Teixeira Magalhães-Guedes

Shijun Pan

Bojan Stojanovic

Karol Chilmon

Shiquan Wang

Bojana S. Stojanovic

Karthik Kannan

Shiva Shankar Reddy

Bojana Vidovic

Kasireddy Sudarshan

Shuai Yuan

Bozena Gajdzik

Katarzyna Mądra-Gackowska

Shun Yao

Byoungwook Ahn

Kavipriya Thangavel

Shuo Liu

Caio Santos Bonilha

Keith Watts

Siham Bakkouri

Carlos Cerdán Santacruz

Kelcie Slaton

Silviu Beciu

Carlos Marcuello Anglés

Kesavan Nair

Simone Galano

Carolin Hannusch

Ketan M. Ranch

Simone Treccarichi

Catalin Bulai

Khrystyna Lipianina-Honcharenko

Sina Sarfarazi

Cátia Sousa

Khursheed Ahmad

Sinan Chen

Changning Liu

Kinga Korniejenko

Sing-Chung Li

Chanin Khomlaem

Kiwon Lee

Sivakumar Jeyarajan

Chao Fu

Konrad Szychowski

Slađana Popović

Chao Zheng

Konstantin Alexandrovich Rybakov

Slavica Miladinovic

Chen Kim Lim

Konstantinos Arsenopoulos

Slobodanka Galovic

Cheng Fang

Koulla Parpa

Sofoklis Stavros

Cheng Li

Kun Yang

Somya Agrawal

Chengling Lu

Kuo-Chien Liao

Song Yu

Chenkang Liu

Lambert Zixin Li

Sotomi Ishihara

Chigozie Andy Ngwaba

László Orlóci

Stanisław Pietrzyk

Chih-Wei Zeng

Laura Diaconu Maxim

Stefanos Kourtis

Chin-Feng Lin

Laxman Subedi

Stepan Dzhimak

Ching-Ta Lu

Leilei Wei

Sudarshan Singh

Chunxiao Li

Leonidas Trakolis

Suhan Zhang

Corina Aurelia Zugravu

Liang Zheng

Süleyman Çınar Çağan

Costel Plescan

Lijana Maskeliūnaitė

Swati Dahariya

Cristian Ciobanescu

Liliya Demidova

Syed Asad Ali Zaidi

Cristina Dumitru

Lorena Del Carmen Espina Romero

Szymon Suwała

Dajun Liu

Lorentz Jäntschi

Tae Young Ko

Dan Valeriu Voinea

Luca Giacomelli

Tao Ni

Daniel Badulescu

Luciana Rotaru

Tarek Berghout

Daniel Miron Brie

Luis Miguel Pires

Tatiana Fedotcheva

Daniel Piotr Potaczek

Luis O. Viteri Jumbo

Tatiana V. Vygodina

Daniel Sanin-Villa

Lvyang Ye

Tetsuya Tanioka

Danijela Smiljanic

Maconi Teixeira

Theoharis Babanatsas

David Michel De Oliveira

Madina Isametova

Thomas Roule

Daxin Dong

Magdalena Pietrzak

Tiago Lima De Albuquerque

Dejan Ćirin

Mahendra Kumar Samal

Tiziana Maria Sirangelo

Dejan Vasovic

Mahmoud Owais

Tomáš Toporcer

Deju Zhang

Maja Hitl

Tomasz Koczorowski

Denis Stanescu

Maksim Iavich

Tomyslav Sledevič

Derya Arslan

Małgorzata Rataj

Tudor Sorin Pop

Di Tian

Manal Fawzy

Tuğba Kuru Çolak

Dignesh Khunt

Mansoor-Ali Vaali-Mohammed

Tuo Zeng

Dikshat Gupta

Manuel De La Sen

Tzu-Hurng Cheng

Dimitrios Doukas

Manuel Saba

Vahdettin Demir

Dimitrios Fanourakis

Manuele Cesare

Valdivino Domingos de Oliveira Júnior

Dina Khoudaer

Marcelo Kaminski Lenzi

Vanessa Bergamin Boralli

Dmitriy Tverdyi

Marcia Bastos Convento

Vasile Razvan Filimon

Dmitry Erokhin

Márcio Vargas-Ramella

Vasileios Greveniotis

Domenico Rosa

Marco Cavaco

Vasily Lubashevskiy

Dominika Gajdosikova

Marco Eigenfeld

Vasudeva Reddy Netala

Dominika Guzek

Marco Fogante

Vesselin Gueorguiev

Dong Wook Shin

Marco Vincenzo Valente

Vicente Borja Jaimes

Dong Zhao

Marcos Antonio Japiassu Resende Montes

Vicente González-Prida

Donghyun Lee

Marcus Goncalves

Victor Abiola Adepoju

Dongwang Wu

Marek Wozniak

Vidyasrilekha Sanapalli

Dongzhao Jin

María Guadalupe Frías-De-León

Vikas Mehta

Douglas Watts

Maria Pia Di Palo

Vilmar Steffen

Dragana Filipovic

Marian Palcut

Vincenzo Mirco La Fazia

Duc Hung Pham

Marianna Olivadese

Vincezo Cuteri

Dulani Meedeniya

Marielena Saivish

Virginia-Maria Rădulescu

Dumitru Toader

Marija R. Popović-Nikolić

Vlad Stoian

Dursun Zafer Seker

Marina Konuhova

Walaa Salah

Eber Quintana-Obregón

Marino Paroli

Walter R. Schumm

Eduarda Vieira

Marios Christodoulou

Wang Chun Kwok

Eduardo Alvarez-Duarte

Mariusz Bialecki

Weber Da Silva Robazza

Eduardo Fernandes

Marko Bašković

Wei Ling

Edwin M. Pino-Vargas

Marko Slavković

Wei-Biao Liao

Efraín Villamor Herrero

Massimo Pacella

Weichen Zhan

Ehab Ali

Matteo Angelo Fabris

Weiwei Han

Ehab AlShamaileh

Matteo Conti

Welson Bassi

Ehsan Hosseini

Matteo Pellegrini

Wen Chen

Ekaterina Lesovaya

Maurizio Sabbatini

Wiktor Stopyra

Elcio Ferreira Dos Santos

Maxim Polyakov

Wilhelm Londono

Elena Tchetina

Mazen Al-Kheetan

Wilhelm Mistiaen

Elina Margarida Ribeiro Marinho

Mehmet Das

William Aperador

Elnaz Amirahmadi

Mehmet Palanci

Wojciech Niemczyk

Eloy Conde

Melissa Anne Beryl Vogt

Xiang Lei

Elvira Rozhina

Menaouar Berrehil El Kattel

Xiang Zhang

Emad A. Az-Zo'bi

Meng Zhang

Xiangchen Meng

Emmanouil Georgios C. Tzanakakis

Michael Halim

Xiao Jian Tan

En Lu

Michal Stosiak

Xiaohai Zheng

Enrique Cervantes Pérez

Michał Zarobkiewicz

Xiaokang Ma

Eqram Rahman

Michele Paolantonio

Xiaoxi Hu

Erand Llanaj

Mika Merviö

Xin Li

Eungi Kim

Mikhail Akimov

Xin Yang

Evangelos Tsiaras

Mikhail Arbatsky

Xin Zhang (Henan Institute of Science and Technology)

Fabio Massimo Oddi

Mikhail Statkus

Xin Zhang (Tianjin Normal University)

Fahad Al Basir

Milan Lal

Xinfa Tang

Faïçal Brini

Milica Dimitrijevic Stojanovic

Xinxin Zhao

Fanglei Zhong

Miłosz Huber

Xinyan Peng

Faseeulla Mohammad

Ming Wu

Xu Li

Fayyaz Qureshi

Minh Tam Schlosky

Yang Shen

Fazlurrahman Khan

Mira Chitt

Yanlin Shi

Federico Minelli

Mirela Jimborean

Yanlong Ji

Fei Han

Mirela Lučan Čolić

Yasir Rasool

Fei Yu

Miriam González-Afonso

Yaxsier De Armas

Fekete Mónika

Mirjana Ocokoljić

Yew Hoong Wong

Fengwei Wang

Miroslava Rakocevic

Yile Chen

Fernando França Cunha

Mohamed A. Hassan

Yinbo Gan

Fernando Marson

Mohamed Ibrahem Elhawy

Yinghao Shan

Fernando Monroy

Mohamed-Amine Babay

Yixin He

Filipe Pereira

Mohammad Aldossary

Yong Zhang

Flaviu Mihai Frigură-Iliasa

Mohammad Ali Arjomand

Yonggang Kim

Florian Pape

Mohammad Mofatteh

Yoshiro Horai

Florin Oancea

Mohammad Nurul Matin

Younho Han

Francesco Cali

Mohammad Younis Hajeer

Youqiang Zhang

Francesco Gagliardi

Mohammed Abdulrasak

Yuan Chen

Francisco Delgado

Mohammed Alnaim

Yuanjie Deng

Francisco E. M. Silveira

Mohammed M. Gomaa

Yuchen Wang

Francisco Guillen-Grima

Mohd Ismail Ibrahim

Yue Cheng

Francisco Rafael Trejo-Macotela

Mohd Usman Mohd Junaidi

Yue Ma

Fredrick N. Eze

Moisés Tolentino Bento Da Silva

Yue Tan

Fredy Hoyos Velasco

Monika Michalska

Yufei Gao

Fuhaid Alshammari

Mostafa Shooshtari

Yunchao Tang

Gabriel Marín Díaz

Mothana Mustafa Gasaymeh

Yuniel Méndez-Martínez

Gabriel Sperandio Milan

Mubarak A. Alanazi

Yuri Tokarev

Gabriela Ignat

Mudasir Younis

Yurii Syromyatnikov

Gamal Ebrahim

Muhammad A. Butt

Yury V. Ilyushin

Gang Hui

Muhammad Jamil

Yuyan Pan

Gaydaa Al-Zohbi

Muhammad Munir

Zbigniew Raszewski

George Karabatsos

Muhammad Waseem

Zbigniew Waśkiewicz

Gerardo Fuentes-Vilugrón

Muntean Calin

Zeashan Khan

Gerasimos Pagiatakis

Murat Demiral

Zeesham Abbas

Giovani Telli

Mussa Makran

Zhao Li

Gleb Zaitsev

Mustafa Bora

Zhen Zhang

Golap Kalita

Mustafa Zeybek

Zheng Lu

Gonzalo Emiliano Aranda-Abreu

Muzaffar Iqbal

Zheng Yuan

Goran Marinkovic

Nafiu Olanrewaju Ogunsola

Zhengchang Wu

Guangliang Xing

Nagendra Verma

Zhenhua Zhang

Guanjun Yang

Nam Deuk Kim

Zhenyu Liu

Guanzhou Ji

Narayanaswamy Venketasubramanian

Zhiguo Meng

Guilherme Welter Wendt

Natalia Kurhaluk

Zhouli Liu

Guillermo Berumen-Varela

Natalija Čutović

Zhuofu Liu

Guna Sekhar Sajja

Natesan Thirumalaivasan

Zied Ben Hazem

Guojie Xie

Nebojša Jurišević

Zihan Qu

Hajer Ben Ammar

Nevien Elhawat

Zongwu Chen

Hamid Ghazi Sulimany

Nguyen Thi Thanh Binh

Zorica Mojović

Hamid Osman

Nicolás Amigo

(Note: we respected all privacy preferences, with part of nominees opting for limited attribution.)

2 July 2026
MDPI INSIGHTS: The CEO’s Letter #36 – Basel Anniversary Summit, 2025 Impact Factors & CiteScores, CSAL Partnership & ncRNA2026

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Reflections from the MDPI 30th Anniversary Summit in Basel

On 4 June, we welcomed 30 Editors-in-Chief (EiCs) from across Europe, North America, and Asia-Pacific to A 66, MDPI’s former headquarters in Basel, for our 30th Anniversary Summit.

In the middle of the year that we celebrate 30 years since MDPI’s founding in 1996, the Summit provided an opportunity to reflect on our journey and recognize the academic community that has helped shape MDPI over the past three decades.

Designed as a small invitation-only event, the Summit brought together long-standing editorial leaders whose experience and perspectives continue to shape our journals. Throughout the day, one message emerged consistently: strong journals are built together, through partnership between publishers, editors, reviewers, and researchers.

MDPI at 30

During my opening presentation, I reflected on MDPI’s evolution from a single journal (Molecules) to a global Open Access (OA) publisher supporting more than 500 peer-reviewed journals, thousands of editors, and millions of researchers worldwide.

While our growth has been significant, our purpose remains unchanged: to help researchers communicate their work openly, efficiently, and responsibly.

I also took the opportunity to recognize that MDPI’s success has never been achieved alone. It has been built alongside our EiCs, Editorial Board Members, reviewers, authors, institutional partners, and colleagues around the world.

Agenda

The agenda combined moments for reflection, discussion, and direct engagement with our guests. The event was moderated by Damaris Critchlow (Editorial Engagement Manager, MDPI) and the program focused on dialogue rather than presentations alone, combining expert talks, panel discussions, and open forums covering:

  • MDPI at 30: reflections and the road ahead
  • Research integrity and editorial responsibility
  • Partnerships and collaboration in publishing
  • Editorial leadership and journal development
  • Artificial intelligence and the future of scholarly publishing

Research Integrity and Editorial Responsibility

A key theme throughout the summit was the continued importance of research integrity and editorial independence. Tim Tait-Jamieson provided an overview of MDPI’s approach to publication ethics, emerging industry challenges, and ongoing investments in prevention, detection, and post-publication oversight. This was a key topic, as it created discussions on the evolving role of publishers, editors, and institutions in safeguarding the scientific record while maintaining transparency and trust.

Editors Panel: Building Journals and Communities

The EiC panel focused on the role of editorial leadership in developing journals and academic communities. Discussions highlighted the importance of active editorial boards, constructive peer review, community engagement, and maintaining quality as scholarly publishing continues to evolve. Thank you to our panelists: Dr. Ester Ballana (Viruses), Dr. Dilantha Fernando (Plants), and Dr. Ting Chi (Journal of Theoretical and Applied Electronic Commerce Research).

MDPI Panel: The Future of Scholarly Publishing

We also had a roundtable discussion on the future of scholarly publishing. Topics included:

  • Artificial intelligence and its role in publishing workflows
  • Technology and innovation in scholarly communication
  • Research integrity and quality assurance
  • The future of peer review
  • Open Access and Open Science
  • The evolving expectations of researchers, institutions, and funders

Recognizing Editorial Leadership

A highlight of the Summit was recognizing EiCs whose long-term leadership has helped strengthen both their journals and their research communities.

Through the Decade of Editorial Leadership Award and the Outstanding Editorial Impact Award, we celebrated individuals whose dedication has made a lasting contribution to scientific publishing.

As we look ahead to MDPI’s next chapter, partnerships with our editors and the wider academic community will remain central to everything we do.

Thank You

My sincere thanks to everyone who participated, and to the many colleagues whose planning and commitment made the Summit such a memorable event.

Impactful Research

2025 Impact Factors Released

June marked another important milestone, with the release of the 2025 Journal Citation Reports (JCR).

Learn more: https://www.mdpi.com/about/announcements/17055

This year:

  • 330 MDPI journals received a Journal Impact Factor
  • 254 journals increased their Impact Factor
  • 29 journals received their first Journal Impact Factor
  • 71% of ranked journals are now positioned in Q1 or Q2
  • MDPI publications have now accumulated 25 million citations

While journal metrics should never be viewed as the sole measure of research quality, they remain an important indicator of journal visibility, community engagement, and scientific influence.

These achievements reflect the collective work of our Editors-in-Chief, Editorial Board Members, reviewers, authors, Publishing teams, and everyone involved in developing our journals.

Congratulations to every journal team that contributed to these results.

Inside MDPI

MDPI Journals Receive 2025 CiteScores

In June, Scopus published the 2025 CiteScores, providing another positive indication of the continued development of MDPI journals.

You can find more details about the 2025 CiteScore release here: Open Access, Broadly Recognized: 363 MDPI Journals Receive CiteScores for 2025

This year’s highlights include:

  • 363 journals received a CiteScore
  • 41 journals received a CiteScore for the first time
  • 314 journals (86%) rank in Q1 or Q2
  • 42 journals are now within the top 10% of their subject categories

Although no single metric defines journal quality, these results demonstrate the continued recognition and visibility of our journals across many research disciplines.

Particularly encouraging is the growing number of journals receiving their first CiteScore, reflecting years of sustained editorial development, successful indexing, and close collaboration between our Publishing teams, Indexing team, editors, and academic communities.

Thank you to everyone across MDPI whose daily work contributes to these achievements.

Coming Together for Science

Supporting Open Access in Switzerland: MDPI Renews Agreement with CSAL

I am pleased to share that MDPI has renewed its Open Access (OA) publishing agreement with the Consortium of Swiss Academic Libraries (CSAL), extending support for researchers across 24 Swiss institutions through our Institutional Open Access Program (IOAP).

As a Swiss-founded publisher, we are particularly proud to continue supporting Switzerland’s research community through long-term institutional partnerships that improve accessibility to Open Access publishing.

The renewal also coincides with the release of our 2025 Switzerland Country Report, highlighting continued national leadership in Open Science. Between 2021 and 2025, Switzerland maintained an OA publication rate of approximately 65–70%, while more than 14,000 Switzerland-affiliated papers have been published with MDPI since 2021.

“We are particularly proud to continue supporting Switzerland’s research community”

The announcement also received coverage across several leading international publishing and research news platforms, including STM, Research Information, EurekAlert!, Bytes Europe, and EdTech Innovation Hub, helping increase visibility for both the partnership and the broader discussion around OA.

My thanks to our IOAP, External Affairs, Communications, and Publishing teams, whose work continues to strengthen relationships with institutions around the world.

Closing Thoughts

Highlights from MDPI Conference ncRNA2026 in Leuven, Belgium (24–26 June)

From 24–26 June, MDPI hosted the ncRNA2026: From Molecular Mechanisms to Clinical Impact Conference in Leuven, Belgium.

The conference welcomed 125 participants from 22 countries and territories, providing an international forum for exchange across molecular biology, medicine, biotechnology, artificial intelligence, and translational research.

Bringing the Global Research Community Together

Over three days, participants exchanged ideas through:

  • 4 Chair Talks
  • 8 Invited Lectures
  • 29 Selected Oral Presentations
  • 51 Poster Presentations

Sessions covered topics including molecular biology, clinical applications, artificial intelligence, and emerging non-coding RNA research, creating a dynamic forum for scientific exchange.

Beyond the scientific program, the conference created opportunities for researchers, journal teams, sponsors, and academic partners to exchange ideas, build existing relationships, and create new collaborations across the global research community.

Our thanks to Conference Chairs Professors George Calin, Manuela Ferracin, Eleonora Leucci, and Isidore Rigoutsos, together with the invited speakers, for delivering an outstanding scientific program.

“By creating opportunities for researchers to exchange ideas, we continue to support the advancement of research worldwide”

Recognizing the Team

The conference also took place during an exceptional heatwave in Belgium, with temperatures reaching 38°C. Thanks to the excellent planning by the Conference team and collaboration with the venue, additional cooling measures and attendee support ensured that the event ran safely and successfully despite challenging conditions.

It is often these behind-the-scenes efforts that make the greatest difference to the participant experience. Thank you to everyone involved for your professionalism, flexibility, and commitment throughout the event.

Thank You

My sincere thanks to the Conference Chairs, invited speakers, sponsors, Editorial Office, Conference team, Marketing colleagues, volunteers, and everyone who contributed to making ncRNA2026 such a success.

As MDPI celebrates its 30th anniversary, events such as ncRNA2026 remind us that our contribution extends well beyond publishing journals. By creating opportunities for researchers to exchange ideas, establish collaborations, and build scientific communities, we continue to support the advancement of research worldwide.

Thank you for your continued dedication throughout another busy month, and I wish you all an enjoyable July!

Stefan Tochev
Chief Executive Officer
MDPI AG

17 June 2026
2025 Impact Factors Released

Impact Factors measure how often articles in scientific journals are cited—specifically, the average number of citations received in a given year by articles published in that journal over the previous two years, as tracked in the Web of Science. For researchers, the number answers a practical question: how often is work published in this journal being picked up and built upon?

The metric is assigned to the journal as a whole, not to individual articles. A high Impact Factor tells you something useful about a journal's place in its field; it tells you less about any single paper within it.

For a complementary, article-level view, MDPI lists an Altmetric score on each article page. Where the Impact Factor tracks academic citations, the Altmetric score captures broader online attention: how an article is being shared, discussed, and referenced beyond the journal literature. Together, they offer two different ways of asking the same question: is this research reaching people?

With 2025 CiteScores from Scopus published a few weeks ago, Clarivate has now released this year's Journal Impact Factors in the Journal Citation Reports (JCR).

254 MDPI Journals Saw a Rise in Impact Factor

This year's JCR include 330 MDPI journals across a wide range of disciplines. Of these, 231 journals are placed in the top 50% (Q1 or Q2) of their respective subject categories, a result that spans fields as different as materials science, public health, environmental studies, and mathematics. 78 journals hold a top-quartile position (Q1), and 33 journals have a JIF of 5.0 or above.

  • 330 journals earned a Journal Impact Factor (JIF)
  • 29 journals earned a first JIF
  • 254 journals had an increase in JIF
  • 71% of ranked journals are in Q1 or Q2

For the full metrics on any MDPI journal, visit our Web of Science journals overview page or a journal's individual statistics page.

29 MDPI Journals Received Their First Journal Impact Factor

A first Impact Factor is a confirmation for an emerging journal. It marks the point at which a journal has been publishing long enough, and cited broadly enough, to enter the formal record of scientific influence. For the research communities those journals serve, it signals that the work being published is being read and built upon.

This year, 29 MDPI journals received a Journal Impact Factor for the first time, across a range of emerging and established research areas. Each represents years of editorial development and peer review—recognized in 2026 for the first time in the JCR.

This is also part of a longer shift in how science gets indexed. When the Emerging Sources Citation Index (ESCI) launched in 2016, 24 MDPI journals were included. By 2024 that number had grown to over 200, reflecting a broader change in the visibility of open access publishing within major citation tracking systems, not just at MDPI but across the sector.

Open Access with Impact

MDPI journals have received a total of 25.2 million citations in Web of Science. That figure matters less as a measure of MDPI's reach and more as a measure of what happens when research is freely available: it gets found, read, and used. Open access is only meaningful if the work actually travels and citations are one indicator that it does.

More than 4.6 million authors have published with MDPI. That breadth, across disciplines, institutions, and geographies, is what makes open access at this scale worth doing.

Thank You to the MDPI Scholarly Community

These results belong to the people who do the actual work: the Editors-in-Chief who set the standards, the Editorial Board Members and reviewers who hold them, and the authors who choose open access for their research. The numbers in the Journal Citation Reports are the downstream effect of decisions made at the desk, in the review, and at submission. Thank you for making them.

Data: 2025 Journal Impact Factors, Journal Citation Reports™ (Clarivate, 2026)

17 June 2026
Zoonotic Diseases | Interview with the Authors—Dr. Kingsley Emmanuel Bentum, Ms. Viona Osei and Dr. Emmanuel Kuufire


Recommendation from Editor-in-Chief: “The review, entitled “Salmonellosis in Cattle: Sources and Risk of Infection, Control, and Prevention”, by Bentum et al. provides a valuable synthesis of insights into the increasingly important global zoonotic public health challenges of salmonellosis from the perspective of cattle production and explores diverse measures that can be implemented to mitigate the threats of infection with this pathogen. Effective prevention and control measures for Salmonella infections of cattle are needed to prevent the prominent food-borne transmission to humans of these bacteria that are increasingly characterized by emergence of multidrug resistant strains. Bentum et al. examine risk factors for introduction and persistence of Salmonella on cattle farms, explore intervention strategies, and conclude that a holistic, all stakeholders, farm focused approach is needed to reduce introduction of Salmonella into the human food chain.” – Prof. Dr. Stephen K. Wikel 

“Salmonellosis in Cattle: Sources and Risk of Infection, Control, and Prevention”
by Kingsley E. Bentum, Emmanuel Kuufire, Rejoice Nyarku, Viona Osei, Stuart Price, Dianna Bourassa, Temesgen Samuel, Charlene R. Jackson and Woubit Abebe
Zoonotic Dis. 2025, 5(1), 4; https://doi.org/10.3390/zoonoticdis5010004
Available online: https://www.mdpi.com/2813-0227/5/1/4

 1. Could you briefly introduce yourself and describe your main research focus?
Dr. Kingsley Emmanuel Bentum: I am a researcher in veterinary and food safety sciences with a strong interest in zoonotic pathogens and their impact on both animal and public health. My research focuses primarily on foodborne bacterial pathogens, particularly Salmonella, and how these organisms move through animal production systems and eventually affect humans. I am especially interested in understanding the transmission dynamics of these pathogens in food animals, the growing challenge of antimicrobial resistance, and evidence-based strategies for disease prevention and control within a One Health framework. My work aims to bridge the gap between veterinary medicine, food safety, public health, and emerging technologies. I am interested not only in identifying pathogens but also in understanding the environmental, management, and behavioral factors that contribute to their persistence and spread. Ultimately, my goal is to contribute to safer food systems, improved animal health, and reduced risks of zoonotic disease transmission to communities worldwide. 

Ms. Viona Osei: I am a PhD candidate specializing in foodborne pathogens, particularly Listeria and Salmonella. My research takes a multidisciplinary approach, combining microbiology, molecular biology, genomics, and bioinformatics to study the detection, differentiation, and transmission of foodborne pathogens. A key focus of my work is understanding how these organisms move through the food chain and the environmental, animal, and production factors that facilitate their transmission to humans. I adopt a One Health perspective, linking environmental, food, animal, and human health to better understand and mitigate food safety risks. I am particularly interested in microorganisms that have major implications for public health. My work is driven by curiosity about microbial behavior in food production environments and a goal of improving food safety through stronger scientific evidence. 

Dr. Emmanuel Kuufire: I’m Emmanuel Kuufire, a PhD student in interdisciplinary pathobiology. My research focuses on zoonotic diseases, food safety, and pathogen surveillance. I am particularly interested in Salmonella epidemiology, antimicrobial resistance, the use of machine learning, bioinformatics and other statistical approaches to improving disease prevention and control through detection in animal production systems and various clinical settings. 

2. What motivated you to pursue this field of zoonotic diseases?

Dr. Kingsley Emmanuel Bentum: What motivated me most was recognizing how closely connected animal health, environmental health, and human health truly are. Many infectious diseases that affect humans originate from animals, and foodborne outbreaks linked to livestock continue to pose serious global public health concerns. Seeing the real-world impact of these diseases inspired me to pursue research that could contribute to preventing infections before they reach people. For me, zoonotic disease research is not only a scientific pursuit but also a way of contributing to society in a meaningful and long-term way. I became particularly interested in how preventive strategies at the animal production level can reduce downstream human infections and improve food safety overall. My motivation is also rooted in the desire to help integrate both animal and human health systems while contributing solutions that benefit people and communities over time. In addition, the interdisciplinary nature of the field attracted me greatly. Zoonotic disease research combines microbiology, epidemiology, veterinary medicine, food safety, public health, bioinformatics, and, increasingly, data science and artificial intelligence. This creates opportunities to develop innovative approaches to disease surveillance, prediction, and prevention that can have a broad global impact. 

Ms. Viona Osei: My motivation comes from a strong interest in microbiology and a desire to understand biological systems that directly affect food safety and human health. I am fascinated by how microorganisms interact within food systems and influence outcomes that impact everyday life. Over time, I became especially interested in zoonotic and foodborne pathogens because of their complex transmission pathways between animals, food, and humans. This field allows me to connect fundamental microbiology with real-world public health challenges. Ultimately, my goal is to contribute to improving food safety and reducing microbial risks through better scientific understanding. 

Dr. Emmanuel Kuufire: I was motivated by the growing impact of zoonotic diseases on public health and food safety. Understanding how pathogens move between animals and humans inspired me to contribute to research that supports disease prevention and safer food systems. 

3. What direction do you think your field is heading towards?

Dr. Kingsley Emmanuel Bentum: I believe the field is increasingly shifting toward prevention at the pre-harvest level, particularly on farms and within animal production systems. Traditionally, much emphasis has been placed on detecting pathogens during food processing and post-harvest stages. However, there is growing recognition that controlling pathogens at their source is one of the most effective ways to improve food safety and protect public health. Future research will likely focus more on proactive rather than reactive approaches. Instead of responding after outbreaks occur, researchers and public health professionals are now exploring methods to predict zoonotic outbreaks before they even begin. This includes improving pre-harvest detection systems, developing real-time surveillance strategies, and identifying environmental and management-related risk factors that contribute to pathogen emergence and spread. Another major direction is the integration of advanced technologies such as artificial intelligence, machine learning, genomics, and Big Data analytics. These tools have enormous potential to enhance predictive investigations, identify disease trends earlier, and improve decision-making in animal and public health systems. I believe that combining biological sciences with computational and predictive technologies will play a major role in the future of zoonotic disease research and food safety management. The One Health approach will also continue to grow in importance, encouraging stronger collaboration among veterinarians, physicians, environmental scientists, epidemiologists, and policymakers in addressing complex disease challenges globally. 

Ms. Viona Osei: I believe the field is becoming increasingly interdisciplinary, which is essential for addressing complex zoonotic disease challenges. Researchers are now combining microbiology, veterinary science, environmental health, and public health to better understand disease systems as a whole. This integrated approach is helping create a more comprehensive understanding of how zoonotic diseases emerge and spread, thereby improving prevention and control strategies. 

Dr. Emmanuel Kuufire: The field is moving toward more interdisciplinary and technology-driven approaches, including genomics, artificial intelligence, and predictive disease surveillance. There is also increasing emphasis on the One Health approach, which connects human, animal, and environmental health. 

4. Why did you choose MDPI’s Zoonotic Diseases as a platform for your work? Do you have suggestions for other scholars who are unsure which journal to submit to?

Dr. Kingsley Emmanuel Bentum: One of the main reasons we selected Zoonotic Diseases as the platform for this work was its strong emphasis on interdisciplinary research connecting animal health, human health, and public health. Our review addressed transmission pathways, risk factors, prevention strategies, and the broader public health implications of salmonellosis in cattle, making the journal a natural fit for our study. 

Ms. Viona Osei: We chose Zoonotic Diseases because it aligns well with the scope of our research and its One Health focus. The journal provides a suitable platform for studies that bridge microbiology, veterinary science, and public health, ensuring that the work reaches an audience directly engaged in zoonotic disease research and control. For researchers selecting journals, I would suggest carefully matching the scope of the journal with the study’s central message and intended audience, especially for interdisciplinary One Health research. 

Dr. Emmanuel Kuufire: We chose Zoonotic Diseases because the journal aligns well with our research interests in public health and animal-associated diseases. For other researchers, I would recommend selecting journals that closely match the scope of their work and target audience rather than focusing only on impact factor. 

5. Regarding your paper, “Salmonellosis in Cattle: Sources and Risk of Infection, Control, and Prevention,” what would you consider as being the main impact of this study?

Dr. Kingsley Emmanuel Bentum: One of the major impacts of this study is that it reinforces the importance of viewing cattle farms and animal production systems as critical control points in preventing zoonotic foodborne disease transmission. Rather than focusing only on contamination during processing or retail stages, the paper highlights the need for preventive interventions earlier in the production chain. The review provides a comprehensive overview of the major sources and risk factors associated with salmonellosis in cattle, including environmental contamination, feed, water, animal management practices, and antimicrobial resistance concerns. By bringing together current knowledge on transmission dynamics and prevention strategies, the paper helps emphasize the importance of integrated control measures across the entire food production continuum. Another key contribution is the emphasis on collaboration under a One Health framework. Effective prevention of zoonotic diseases such as salmonellosis requires coordinated efforts among farmers, veterinarians, researchers, public health professionals, regulators, and the food industry. The paper highlights how interdisciplinary cooperation is essential for improving disease surveillance, strengthening biosecurity, reducing antimicrobial resistance risks, and ultimately protecting public health. We also hope the review encourages greater investment in preventive research, surveillance systems, and evidence-based farm management practices that can reduce pathogen transmission before it reaches the consumer level. 

Ms. Viona Osei: The main impact of this study is to highlight cattle production systems as a key point for preventing human salmonellosis. It shows how Salmonella can enter and persist in herds, making farm-level prevention critical to reducing risks in the food chain. The study also underscores the need for a One Health approach that involves farmers, veterinarians, industry stakeholders, and regulators. Strengthening surveillance, biosecurity, and early intervention is essential for effective control. 

Dr. Emmanuel Kuufire: The study highlights the important role cattle play as reservoirs of Salmonella and summarizes key risk factors, transmission routes, and prevention strategies. It contributes to better understanding and awareness of foodborne disease control in livestock systems. 

6. What are the main challenges in your field when conducting research?

Dr. Kingsley Emmanuel Bentum: One major challenge in zoonotic disease research is the complexity of disease transmission itself as most pathogens often move simultaneously through animals, humans, wildlife, food systems, and the environment. This makes it difficult to identify and control every contributing factor. These interconnected pathways require multidisciplinary collaboration and large-scale data collection, which can be both scientifically and logistically demanding. Additionally, translating research findings into practical and widely adopted interventions can be challenging. Scientific recommendations must often balance animal health, economic realities, farm management practices, and public health priorities simultaneously. Despite these challenges, the field remains highly rewarding because of its direct impact on food safety, animal welfare, and human health globally. 

Ms. Viona Osei: A key challenge is engaging effectively with stakeholders such as farmers and livestock producers. Research findings related to pathogen detection can sometimes raise concerns about animal health status or production practices. This makes communication and trust-building essential. Researchers must present findings clearly and responsibly, ensuring that results are interpreted in context and can be used constructively to improve food safety without creating unnecessary alarm. 

Dr. Emmanuel Kuufire: Some major challenges include limited funding, difficulties in long-term surveillance, antimicrobial resistance, and the complexity of tracking pathogen transmission between animals, humans, and the environment. 

7. Do you have advice regarding publishing and peer-review for other fellow early career researchers and/or PhD students working in this area?

Dr. Kingsley Emmanuel Bentum: My advice to early career researchers and PhD students is to view peer review as a valuable learning opportunity rather than as criticism. Reviewer comments, even when challenging, can significantly strengthen a manuscript if approached constructively and professionally. Some of the most impactful improvements in scientific papers often come through the revision process. Persistence is also extremely important in academic publishing. Rejections, revisions, and delays are normal parts of the research journey and are experienced by nearly every researcher. It is important not to become discouraged by setbacks. Instead, focus on continuously improving your scientific writing, research design, and analytical skills over time. Finally, I believe researchers should prioritize conducting meaningful and scientifically rigorous work rather than chasing publication numbers alone. High-quality research that addresses real-world problems and contributes to public health will always have a long-term impact and value. 

Ms. Viona Osei: For early career researchers, it is important to clearly connect zoonotic findings to human health relevance while maintaining methodological rigor and reproducibility, especially in genomic analyses. Avoid overinterpreting transmission patterns and ensure conclusions are well supported by the data. Focus on key findings rather than excessive detail, and use a clear One Health framing only when it is justified by the results. Being transparent about limitations, seeking informal peer feedback before submission, and selecting journals strategically can significantly improve clarity, impact, and acceptance outcomes. 

Dr. Emmanuel Kuufire: My advice is to stay persistent, be open to feedback, and focus on producing quality research. Peer review should be seen as an opportunity to improve your work, and collaboration and mentorship are also very important for career development.

8 June 2026
Zoonotic Diseases Receives Its First CiteScore of 2.3

We are pleased to share that Zoonotic Diseases (ISSN: 2813-0227) receives its first CiteScore of 2.3 in June 2026, following its inclusion in Scopus (Elsevier) in 2025. The CiteScore ranks the journal 19 out of 44 titles (Q2) in the “Veterinary (miscellaneous)” category, an impressive achievement for a journal running in Volume 6.

You can find more statistics on our website.

The current CiteScores measure the average number of citations within a journal over a four-year window (2022–2025). The Scopus database provides a comprehensive suite of metrics that support informed publishing strategies, research evaluation and enable benchmarking of journal performance.

This achievement reflects the collective efforts of our authors, reviewers, and editors. Together we will continue to track the progress of Zoonotic Diseases and its growing impact in zoonoses research.

4 June 2026
Open Access, Broadly Recognized: 363 MDPI Journals Receive CiteScores for 2025

The 2025 CiteScore metrics have been officially released by Scopus, and the results confirm what has become a consistent pattern for MDPI's journal portfolio: broad recognition across disciplines, steady improvement across the majority of ranked titles, and a growing presence at the top of subject category rankings.

CiteScore, published annually by Elsevier's Scopus database, measures the average citations received by articles published in a journal over a four-year window. As a complement to the Journal Impact Factor, which uses a two-year window based on the Web of Science database, CiteScore provides an alternative, long-term perspective on citation performance.

The 365 MDPI journals in Scopus (as of May 2026) are indexed across a wide range of subject categories, ensuring that open access research remains highly discoverable to a global readership through one of the most widely used platforms in academic publishing.

Data Summary (2025 CiteScores)

  • New Additions: 41 MDPI journals received a CiteScore for the first time.
  • Trending Upward: 234 of 322 previously ranked journals (73%) saw an increase in their CiteScore compared to last year.
  • High Visibility: 314 journals (86%) rank in Q1 or Q2 in at least one subject category.
  • Elite Performance: 42 journals rank in the top 10% of their subject categories.

Portfolio Performance

Among the 322 journals that held a CiteScore in 2024, 234 saw an increase this year. Quartile improvements outnumbered declines across the portfolio, with 52 journals moving to a higher quartile and only 20 seeing a decline. Furthermore, no previously ranked journals were removed. The 42 journals now ranked in the top 10% of their subject categories are drawn from a strong foundation of 178 journals holding a Q1 position.

With the large majority of our indexed portfolio ranked in the top half of research fields, researchers can confidently choose MDPI to meet funder mandates for high-quality, fully compliant Open Access publishing.

Exceptional Achievements for Foods and Life

Notably, both Foods and Life achieved a 99th percentile ranking in their respective subject categories for the 2025 CiteScores. This outstanding placement positions them as leading journals in their fields and highlights the high visibility and global impact of the open access research they publish.

Journal Metrics and Beyond

Journal-level metrics describe outlets, not individual articles. An increasing number of funders and institutions—including signatories of DORA and the Coalition for Advancing Research Assessment—now explicitly encourage evaluation at the article level rather than by the journal in which research appears. MDPI supports this direction: we report CiteScore alongside the Journal Impact Factor, Journal Citation Indicator, and article-level usage data because no single number captures the full reach and contribution of published research.

Thank You

These results reflect the sustained effort of thousands of editors-in-chief, editorial board members, reviewers, and authors across every field MDPI serves. The metrics are the outcome; the work is yours.

To explore the specific 2025 CiteScore, Impact Factor, and indexing details for your field's journal, please visit the Scopus journals list and go to a journal's Statistics page.

1 June 2026
MDPI INSIGHTS: The CEO’s Letter #35 – 30 Years of Open Science, Open Access Policies, Spain Summit, MMCS 2026 & Antibiotics 2026

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

30 Years of Open Science, Built Together

This month, we officially launched MDPI’s 30th Anniversary campaign and dedicated anniversary website, marking an important milestone in our journey as an open access publisher. What began in 1996 with a single journal and the simple belief that scientific knowledge should be shared openly and freely has grown into a global publishing organization supporting more than 500 journals, 68,000 Editorial Board Members, and millions of researchers worldwide.

The anniversary page, entitled 30 Years of Open Science, Built Together, reflects on the people, milestones, and partnerships that have shaped MDPI over the past three decades. It includes a retrospective of our development, key moments in the evolution of open access, landmark research articles, journal anniversaries, an interview with the CEO, and perspectives from colleagues and partners who have contributed to our success.

Looking back, one of the most striking aspects of our journey is not simply our growth, but the broader transformation of scholarly publishing itself.

Open access has moved from a niche concept to a widely adopted publishing model, helping make research more accessible, discoverable, and impactful for researchers, institutions, policymakers, and society.

MDPI has been part of this transition and continues to invest in the people, technology, partnerships, and research integrity infrastructure needed to support high-quality open science at scale.

While anniversaries naturally encourage reflection, they are also an opportunity to look ahead. The challenges facing scholarly publishing today, including research integrity, artificial intelligence, accessibility, and global participation in science, will require continued collaboration across the research ecosystem. As we celebrate 30 years of publishing, our focus remains on supporting researchers, strengthening trust in open science, and helping shape the future of scholarly communication together.

I encourage you to visit the anniversary page, explore the milestones, and take a moment to reflect on the role each of us has played in contributing to MDPI’s story.

Thank you for being part of this journey.

Impactful Research

Highlights from MMCS 2026 in Beijing (14-17 May)

From 14–17 May, MDPI hosted The 5th Molecules Medicinal Chemistry Symposium (MMCS 2026) in Beijing, China, bringing together academia and industry to explore advances in chemical biology, medicinal chemistry, and drug discovery.

The conference hosted more than 230 attendees from 37 countries and regions, alongside 257 submissions and 145 accepted abstracts. With a significant increase in attendance – up by 100 participants compared with the previous edition – the popularity of MMCS continues to grow in terms of its international profile and scientific relevance within this rapidly evolving field.

The scientific program covered seven themes:

  • Chemical Biology for Drug Discovery
  • Medicinal Chemistry Research Progress
  • Natural Products in Drug Discovery
  • AI-enabled Drug Discovery
  • GPCR & Ion Channel Targeted Drug Development
  • Innovative Proximity-Based Drug Modalities
  • Biocatalysis for Natural Product & Drug Synthesis

The event featured three plenary speakers, 14 keynote speakers, 35 selected oral presentations, and 98 poster presentations, creating opportunities for open scientific exchange and collaboration. Conference Chair Prof. Dr. Diego Muñoz-Torrero described this edition as one of the most successful MMCS events to date.

Thanks to our Sponsors

MMCS 2026 secured sponsorship support from 12 industrial partners, 11 of which set up on-site exhibition booths. Covering biopharmaceutical R&D, life science supplies, pharmaceutical experimental instruments, and industrial service sectors, exhibitors were able to connect their businesses directly with attendees and make connections at the conference.

30th Anniversary Celebration of Molecules

During the conference, we also celebrated the 30th anniversary of Molecules, one of MDPI’s flagship journals. The celebration brought together Section Editors-in-Chief, Editorial Board Members, MDPI leadership, and editorial colleagues to reflect on the journal’s development, achievements, and continued future growth.

Events such as MMCS 2026 highlight the important role conferences play in creating scientific exchange and collaboration, and in connecting our research communities in person.

They also reflect the continued development of MDPI’s conference portfolio and our commitment to supporting academic engagement beyond publishing alone. Thanks to everyone involved in organizing and contributing to the success of this event.

Inside MDPI

Open Access Policies Continue to Accelerate Globally

One of the clearest indicators of the continued momentum behind open access is the growing number of national and institutional policies supporting, and increasingly requiring, open dissemination of research.

Around the world, governments, funding agencies, and universities are building their open access mandates, with increasing focus on transparency, rights retention, and public accessibility of publicly funded research. While these policies vary across regions, the broader direction is clear: expectations around openness and compliance continue to accelerate.

For researchers, navigating these evolving requirements can be complex and time-consuming. Supporting the research community therefore means not only publishing high-quality open access content but also helping stakeholders better understand changing requirements and emerging opportunities. At MDPI, we see this as an important part of our role within scholarly communication.

“Expectations around openness and compliance continue to accelerate”

Through the MDPI Blog, our Content team continues to publish monthly articles overviewing different countries’ relationships with open access, exploring their histories, policies, opportunities, and statistics. All this information is centralized into an article which contains brief summaries of each country, with links to all the full articles, and is updated monthly.

Recent Policy Developments

South Africa

In 2026, South Africa’s Department of Science and Innovation introduced the South African Open Science Policy. The policy states that: “Open access shall be required for publications arising from publicly funded research, and desirable for research from all sources of funding.”

The policy envisions a coordinated and broad approach to open science that will sustainably and ethically drive socio-economic development by increasing the practice of open science through policy, training, incentivization, and infrastructure.

Canada

In Canada, the Tri-Agency OA Policy on Publications was revised, removing the 12-month embargo for research that must be deposited in a repository with an open license and with author rights retained.

The Agencies argue that “societal advancement is made possible through widespread and barrier-free access to cutting-edge research and knowledge.”

Chile

Chile is a collaborative and engaged member of the global open access movement.

The National Research and Development Agency (Agencia Nacional de Investigación y Desarrollo, or ANID) is Chile’s main funding agency for R&D. It mandates that all beneficiaries must deposit the final version of their published scientific output, with an embargo period of up to 12 months, into a repository.

ANID also supports the InES Open Science funding program, which allows universities to request funding for capacity and infrastructure building. Further, Chile is an active participant in various international initiatives, such as Redalyc, SciELO, and Red de Repositorios Latinoamericanos.

Openness Beyond Research

At MDPI, openness remains one of our core values, ensuring that research outputs are freely accessible to anyone. This commitment also extends to sharing knowledge about the scholarly publishing landscape itself, which we practice on the MDPI Blog through various topics, including open access, recent advances in science, and opportunities for researchers.

As the open access landscape continues to evolve, helping researchers, institutions, editors, and partners navigate these changes will remain an important priority for us.

Thank You

I would like to thank Jack McKenna (Senior Content Specialist, MDPI) from our Content team for his ongoing work on the MDPI Blog series covering global open access policy developments. Initiatives such as this help make complex policy discussions more accessible and useful to the wider research community.

Coming Together for Science

Reflections from the MDPI Spain Summit 2026 in Valencia (21 May)

On 21 May, we hosted the MDPI Spain Summit 2026 in Valencia.

The Summit brought together 30 Editorial Board Members and MDPI colleagues for a discussions on the future of publishing, research integrity, peer review, artificial intelligence, and the evolving research landscape in Spain.

We hosted participants from leading Spanish institutions and spoke on the importance of Spain as a major contributor to global open access (OA) research. In 2025 alone, Spain ranked among the leading countries worldwide for OA publishing, with more than 85% of publications made openly accessible. MDPI also continues to play a significant role within the Spanish research ecosystem.

MDPI in Spain

Spain remains one of MDPI's most important academic markets and a leading contributor to OA research globally. Ever since our Barcelona office opened in 2016 (Happy 10th Anniversary!), MDPI Spain has been actively supporting researchers, institutions, societies, and academic partners across the country. Today, the office plays an important role in creating engagement with the Spanish scholarly community through editorial support, partnerships, conferences, training initiatives, and outreach activities.

A cluster of high-level indicators highlight both the strength of the local research ecosystem and MDPI’s role within it:

  • 43,218 total publications in Spain in 2025, of which 35,728 (83%) were open access (49% Gold OA).
  • 211,200+ total publications (2021–2025), with 84% published open access.
  • 13,444 MDPI publications from Spanish institutions in 2025, representing 14% of all open access publications in Spain.
  • More than115,100 MDPI publications from Spanish institutions since 1996.
  • More than 4,500 Editorial Board Members from Spain, including more than 150 Chief Editors and 57 Associate Editors.
  • 42 institutional partners participating in MDPI’s Institutional Open Access Program (IOAP).
  • Spain ranks second globally for MDPI society affiliations, with 26 affiliated society agreements currently in place.

Program Overview

What made this summit special was the openness of the discussions around the research landscape in Spain and the role MDPI plays within the market. General topics of the presentations included:

  • MDPI Introduction – Stefan Tochev (CEO).
  • Engagement with the Academic Community – Dr. Marta Colomer (External Affairs Lead).
  • Latest Developments in the Editorial Process – Dr. Jordi Martinez (Deputy Managing Editor).
  • Research integrity and Publication Ethics – Slavomir Nikodijevic (Research Integrity Specialist).
  • A 360 View of Academic Publishing – Prof. Dr. Luis Angel Ruiz Fernandez (EBM of Remote Sensing).

Panel Discussion

We also hosted a panel discussion moderated by Marta, entitled “The Future of Academic Publishing” with Prof. Luis Ruiz, Prof. Marta Feliz (EBM of the journal Catalysts), Dr. Enric Sayas (Product Owner, AI & Technology Innovation), and myself. The discussion looked at the evolving role of editors, the future of peer review, and the growing importance of maintaining trust, ethics, and research integrity in an era increasingly influenced by artificial intelligence.

Themes from the Summit

Several themes emerged throughout the discussions, reflecting broader conversations taking place across publishing:

  • The academic community values efficient publishing workflows, but expectations around scientific quality and editorial rigor continue to rise.
  • Reviewer fatigue and long-term sustainability of peer review remain major challenges across the industry.
  • AI is rapidly changing scholarly communication and requires transparent and responsible governance.
  • Reputation and trust continue to depend on long-term engagement, transparency, and quality-focused decision-making.

“Maintaining an open dialogue with researchers, editors, reviewers, and institutions remains a priority for MDPI”

It was constructive to see the willingness of participants to engage directly and candidly with us. These conversations provide insights that help inform how we continue to develop our editorial processes, engagement activities, and support for the research community. While certain discussions included concerns, there was also recognition that open dialogue between publishers and the research community is essential if we want to improve scholarly communication together.

Events such as this are increasingly important for MDPI. They allow us to present our perspective, to listen to the experiences, expectations, and concerns of editors, reviewers, and researchers, and to address these accordingly.

Thank You

Thank you to our Barcelona Office and all colleagues involved in organizing the summit, as well as all participants for contributing to these thoughtful and constructive discussions.

As publishing continues to evolve, maintaining an open dialogue with researchers, editors, reviewers, and institutions remains an important priority for MDPI. Events such as the Spain Summit play an important role in helping us to build relationships, foster trust, and better understand the needs of our community.

Closing Thoughts

Highlights from Antibiotics 2026 in Barcelona (11–14 May)

This week, MDPI hosted the Antibiotics 2026 — Advances in Antimicrobial Action and Resistance conference in Barcelona, bringing together academics and industry experts to discuss one of the most important scientific and public health challenges of our time: antimicrobial resistance.

The conference welcomed 145 attendees from 42 different countries and territories, alongside 265 submissions and 127 accepted abstracts, showing the international reach of the event and the strong scientific interest in this rapidly evolving field.

Scientific Exchange on a Global Challenge

Antimicrobial resistance continues to be a global concern, creating collaboration across disciplines, institutions, and regions. The conference program focused on a range of topics including:

  • Antimicrobial resistance mechanisms
  • One Health approaches to antimicrobial stewardship
  • Discovery of novel antimicrobial agents
  • Innovation in clinical strategies and treatment approaches
  • Ethnopharmacology and emerging therapies

Through keynote plenaries, invited lectures, oral presentations, and poster sessions, the conference created a platform for dialogue and scientific exchange.

International Participation and Collaboration

One of the highlights of the event was the diversity of participation across both geography and expertise. Researchers and speakers from Europe, North America, Asia, Africa, Australia, and Latin America took part in discussions throughout the conference, highlighting the global nature of both the challenge and the scientific response.

The scientific program included:

  • 2 keynote speakers
  • 10 invited speakers
  • 36 selected talks
  • 78 posters

The conference brought together perspectives from academia, healthcare, and industry, helping facilitate interdisciplinary collaboration around future approaches to antimicrobial research and resistance management.

The Role of Conferences in Scholarly Communication

Conferences are an important platform for collaboration, scientific exchange, and community-building. Events such as Antibiotics 2026 show the value of bringing researchers together in person to discuss emerging challenges, share new findings, and strengthen international networks across disciplines and regions.

Thank You

I would like to thank the conference chairs, speakers, participants, sponsors, and the entire MDPI conference team for their work in making this event a success. The engagement and positive feedback from attendees highlight the importance of our events in addressing some of the most pressing scientific challenges facing society today.

Stefan Tochev
Chief Executive Officer
MDPI AG

21 May 2026
Meet Us at the Northern European Conference on Travel Medicine (NECTM10), 3–5 June 2026, Belfast, UK


Conference:
The Northern European Conference on Travel Medicine (NECTM10)
Date: 3–5 June 2026
Location: Belfast, UK

We are excited to announce that MDPI will participate as an exhibitor at the Northern European Conference on Travel Medicine (NECTM10) from 3 to 5 June 2026.

NECTM was founded by twelve travel health organizations and societies in eight countries to meet common educational needs in the expanding multidisciplinary field of travel medicine. The first biennial conference was successfully held in Edinburgh in 2006, followed by Bergen, Hamburg, Dublin, Helsinki, London, Stockholm, Rotterdam, and Copenhagen. Between 500 and 1000 travel medicine specialists and practitioners across Europe and beyond meet every other year to share the latest scientific updates, discuss ideas, interact, learn, and enjoy the experience together—always with smiles on our faces. Every NECTM is unique and reflects current scientific challenges as well as specific travel medicine issues.

If you are planning to attend the above conference, please feel free to reach out to us. Our delegates look forward to meeting you in person at booth 7 and answering any questions that you may have.

For more information about the conference, please visit the following website: https://mkon.nu/nectm_10/nectm.

14 May 2026
Meet Us at the ASM Microbe 2026, 4–7 June 2026, Washington, USA


Conference:
ASM Microbe 2026
Date: 4–7 June 2026
Location: Washington, USA

MDPI will be attending the ASM Microbe 2026 as an exhibitor. We welcome researchers from different backgrounds to visit and share their latest ideas with us.

ASM Microbe 2026 is transforming the way we connect with science. For the first time, they are hosting three independent meetings under one roof and offering the most comprehensive access to cutting-edge research and experts driving discovery in your field.

Delve into your scientific community by attending 1 of 3 distinct meetings—Health, Applied & Environmental Microbiology or Mechanism Discovery. Each offers a focused, in-depth experience tailored to your field, providing the latest research, perspectives and developments shaping the future of microbial science. Wherever your expertise lies, you will find a meeting that speaks directly to your science at ASM Microbe.

  1. Shape the Direction of Microbial Science: Collaborate with peers who are setting research agendas and driving progress across academia, industry and government. ASM Microbe brings together the most accomplished minds across disciplines to advance collective understanding and influence the future of microbial research and application.
  2. Discover Tools, Ideas and Industry Innovations: Visit the dynamic exhibit hall where leading companies showcase the latest technologies, products and solutions. Connect with industry experts, gain insights into emerging tools and uncover opportunities to advance your research and applications.
  3. Uncover the Latest Breakthroughs in Microbial Science: Explore the poster hall and cutting-edge abstracts to discover the newest findings presented by scientists from around the world. Gain insights that advance your research, spark new ideas and reveal trends shaping the future of the field.
  4. Connect With the Brightest Minds: Build collaborations and form new partnerships across academia, industry and government. Network with peers and mentors who can challenge your thinking and amplify your science.
  5. Be Part of the Conversation That Moves Science Forward: ASM Microbe 2026 brings together your community to present research, define priorities, share perspectives and accelerate discovery. From the leading experts shaping the field, to the rising stars driving the next generation of discoveries, this is where leaders convene, game-changing research is unveiled and the next era of microbial science takes shape.

The following open acess journals will be represented:

If you are planning to attend this conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://asm.org/events/asm-microbe/home.

Back to TopTop